Tuesday, 04 August 2020


ParkwayHealth offers HBsAg Quantitative Assay

09 July 2013 | News | By BioSpectrum Bureau

With HBsAg Quantitative Assay, physicians can now receive information about the condition of patients afflicted with Hepatitis B

With HBsAg Quantitative Assay, physicians can now receive information about the condition of patients afflicted with Hepatitis B

Singapore: ParkwayHealth Laboratory, a clinical laboratory service provider in Singapore, is to provide Hepatitis B Surface Antigen (HBsAg) quantitative assay.

With HBsAg Quantitative Assay, physicians can now receive information about the condition of patients afflicted with Hepatitis B and allows better tailoring of treatment and clinical management to the patient. Chronic HBV (hepatitis B virus) patients can use the HBsAg Quantitative Assay to monitor their illness, their response to treatment and predict the potential of developing liver cirrhosis (scarring of the liver) and cancer.

HBsAg Quantitative Assay requires a small blood draw from patients. It adopts a technology called chemiluminescent microparticle immunoassay, which generates light when HBsAg is detected.


Sign up for the editor pick and get articles like this delivered right to your inbox.

Editors Pick
+Country Code-Phone Number(xxx-xxxxxxx)


Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account




Podcast

 

Survey Box

Should we be cautious of viewing COVID-19 vaccine as silver bullet?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls